QiSant™ Initial Publication Demonstrates Strong Clinical Validation of Urine-Based Assay in Kidney Transplant Surveillance

SAN FRANCISCO, March 18, 2020 /PRNewswire/ -- NephroSant, a startup company that is focused on redefining kidney health, today announced the landmark publication showing high accuracy for a urine-based assay for the surveillance of kidney transplant patients to identify rejection. The...

from PR Newswire: https://ift.tt/2QmB2fl